Please use this identifier to cite or link to this item:
|Title:||The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review|
Monika Puri Oktora
Maarten J. Postma
University of Groningen
Universitas Muhammadiyah Purwokerto
Organisation Mondiale de la Santé
University of Groningen, University Medical Center Groningen
|Keywords:||Biochemistry, Genetics and Molecular Biology;Immunology and Microbiology|
|Citation:||Expert Review of Vaccines. Vol.16, No.9 (2017), 933-943|
|Abstract:||© 2017 Informa UK Limited, trading as Taylor & Francis Group. Introduction: The cervical cancer-related burden is an important problem in Southeast Asian (SEA) countries. However, only 3 out of 11 countries implement the comprehensive prevention program. Areas covered: This is a retrospective review from all relevant studies until 2015 from two main databases, MEDLINE/Pubmed and Embase in order to provide an evidence on the health economics of HPV vaccination in the region. Expert commentary: The implementation of HPV vaccination will generate substantial health and economic benefit in SEA countries since the number of cervical cancer cases in this region are generally high. Therefore, a clear recommendation on how HPV vaccination should be implemented in a country, for example on how many doses will be used, how much cost is required or is it a school based- or clinical based-delivery, is critically required.|
|Appears in Collections:||Scopus 2016-2017|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.